Global Periodontal Treatment Market 2022-2028

Global Periodontal Treatment Market 2022-2028

Periodontal disease affects the tissues that surround and support the tooth. It is characterized by swollen gums (gingivitis) or bleeding, pain, and often bad breath. In severe cases, the gum can come away from the tooth and supporting bone, which causes teeth to become loose and usually fall out. Severe periodontal diseases are estimated to affect nearly 10% of the global population. The main causes of periodontal disease include poor oral hygiene and tobacco use. As per the data published World Health Organization (WHO) in March 2021, Severe periodontal (gum) disease, which may result in tooth loss, is highly common, with nearly 10% of the global population affected.

The global periodontal treatment market is growing at a CAGR of 7.6% during the forecast period (2021-2028). Rising incidences of periodontal diseases and increasing awareness regarding oral health are some major factors accelerating market growth. Further, rising dental healthcare expenditure, an increasing number of small/private clinics with dental dispensaries are also contributing to the periodontal treatment market growth. Rising awareness regarding oral health has been witnessed which is resulting in an increasing demand for periodontal treatment. As per the US Centers for Disease Control and Prevention (CDC), in the US, the percentage of adults aged 18 and over with a dental visit was 64.9% in 2021. This is resulting in an increasing demand for periodontal surgical and non-surgical treatment alternatives. However, reimbursement issues and the high cost of periodontal surgery are expected to hinder the market growth.

SEGMENTATION OUTLOOK

The global periodontal treatment market is segmented based on therapy, which includes surgical and non-surgical therapy. Non-surgical therapy includes local antibiotics, systemic antibiotics, and laser treatment. The market for surgical treatment is anticipated to grow at a CAGR of 7.3% during the forecast period. Surgical treatments include bone grafting, flap surgery (pocket reduction surgery), soft tissue grafts, guided tissue regeneration, and tissue stimulating proteins. Bone grafting is a procedure that supports the prevention of tooth loss by holding the tooth in place and acts as a platform for the regrowth of natural bone. A comprehensive range of bone grafting materials has been applied and assessed clinically, which include xenografts, alloplasts, autografts, and allografts. Bone replacement grafts are extensively used to promote bone formation and periodontal regeneration.The surgical treatment market is driven by the growing prevalence of severe cases and the availability of effective options to treat periodontitis.

  New Developments in Non-Surgical Therapies for Periodontal Treatment

Penn Dental Medicine is conducting a clinical trial of PerioSept gel (containing up to 3% taurolidine), a new experimental gel formulation developed by Geistlich Pharma. It is under Phase II clinical trial and serves as adjunctive therapy along with scaling and root planing in subjects with moderate to severe periodontitis. This, in turn, is further support to increase the share of non-surgical therapy for periodontal disease treatment.

REGIONAL OUTLOOK

Geographically, the global periodontal treatment market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World (Latin America and the Middle East & Africa). The market in North America held the highest market share in 2021. The market in North American is growing at a CAGR of 7.6% attributed to the availability of various approved products, well-established dental infrastructure, increase in technological advancements, rise in the number of well-equipped dental clinics, and presence of key players.

COMPETITIVE OUTLOOK

The market players present in the global periodontal treatment market include 3M Co., Dentsply Sirona Inc., The Straumann Group, Bausch Health Companies Inc., and Medtronic plc. The market players are adopting some key strategies to increase their market share. For instance, in July 2021, Cantel Medical Corp. declared that it has reached an agreement to acquire Hu-Friedy Mfg. Co. (Hu-Friedy), a manufacturer of instruments and instrument reprocessing workflow systems serving the dental industry. The acquisition augments the dental division’s supply chain efficiency and enables it to better support its distribution partners while also addressing the increased concern among healthcare professionals in the areas of clinical performance, compliance, technology, education, and training. The acquisition will further support dental professionals to eliminate risk and streamline operations to deliver best-in-class patient care.